Sabre Corpo Stock Alpha and Beta Analysis

SABR Stock  USD 3.76  0.03  0.80%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Sabre Corpo. It also helps investors analyze the systematic and unsystematic risks associated with investing in Sabre Corpo over a specified time horizon. Remember, high Sabre Corpo's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Sabre Corpo's market risk premium analysis include:
Beta
1.89
Alpha
0.22
Risk
3.85
Sharpe Ratio
0.12
Expected Return
0.47
Please note that although Sabre Corpo alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Sabre Corpo did 0.22  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Sabre Corpo stock's relative risk over its benchmark. Sabre Corpo has a beta of 1.89  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sabre Corpo will likely underperform. At this time, Sabre Corpo's Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 11/26/2024, Enterprise Value Multiple is likely to grow to 55.20, though Book Value Per Share is likely to grow to (3.73).
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Sabre Corpo Backtesting, Sabre Corpo Valuation, Sabre Corpo Correlation, Sabre Corpo Hype Analysis, Sabre Corpo Volatility, Sabre Corpo History and analyze Sabre Corpo Performance.
To learn how to invest in Sabre Stock, please use our How to Invest in Sabre Corpo guide.

Sabre Corpo Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Sabre Corpo market risk premium is the additional return an investor will receive from holding Sabre Corpo long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sabre Corpo. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Sabre Corpo's performance over market.
α0.22   β1.89

Sabre Corpo expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Sabre Corpo's Buy-and-hold return. Our buy-and-hold chart shows how Sabre Corpo performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Sabre Corpo Market Price Analysis

Market price analysis indicators help investors to evaluate how Sabre Corpo stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sabre Corpo shares will generate the highest return on investment. By understating and applying Sabre Corpo stock market price indicators, traders can identify Sabre Corpo position entry and exit signals to maximize returns.

Sabre Corpo Return and Market Media

The median price of Sabre Corpo for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 3.4 with a coefficient of variation of 9.43. The daily time series for the period is distributed with a sample standard deviation of 0.32, arithmetic mean of 3.4, and mean deviation of 0.27. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Insider Buying Highlights 3 Undervalued Small Caps In None Region
10/30/2024
2
Sabre Q3 Loss Wider Than Expected Will Weak Results Drag Stock Down
11/01/2024
3
Exploring United Kingdoms Undervalued Small Caps With Insider Buying In November 2024
11/04/2024
4
Why payment firms are betting on embedded finance
11/06/2024
5
Can RNGs Q3 Earnings Beat and Raised FY24 View Push Shares Higher
11/08/2024
6
Acquisition by Mandel Gail of 10000 shares of Sabre Corpo at 3.6287 subject to Rule 16b-3
11/11/2024
7
Director Gail Mandel Buys 10,000 Shares of Sabre Corp
11/13/2024
8
Sabre-toothed kitten mummy unearthed in Siberia is first of its kind
11/18/2024
9
Bernstein reduces Sabre stock outlook, citing cyclical risks and strained financial position
11/19/2024
10
CellPoint Digital Secures 30 Million Funding Round to Accelerate Modern Airline Retailing Transformation
11/21/2024
11
Sabre Earns Underperform Rating from Sanford C. Bernstein
11/22/2024

About Sabre Corpo Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Sabre or other stocks. Alpha measures the amount that position in Sabre Corpo has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.0078460.01060.01050.00944
Price To Sales Ratio1.630.790.520.5

Sabre Corpo Upcoming Company Events

As portrayed in its financial statements, the presentation of Sabre Corpo's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sabre Corpo's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Sabre Corpo's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Sabre Corpo. Please utilize our Beneish M Score to check the likelihood of Sabre Corpo's management manipulating its earnings.
21st of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Sabre Corpo

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Sabre Stock Analysis

When running Sabre Corpo's price analysis, check to measure Sabre Corpo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabre Corpo is operating at the current time. Most of Sabre Corpo's value examination focuses on studying past and present price action to predict the probability of Sabre Corpo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabre Corpo's price. Additionally, you may evaluate how the addition of Sabre Corpo to your portfolios can decrease your overall portfolio volatility.